Skip to main content

Table 3 Base case cost-effectiveness analysis

From: The optimal diagnostic strategies for patient with coronary artery diseases and stable chest pain syndrome: a cost-effectiveness analysis

  Cost ($) Incremental cost Effectiveness Incremental effectiveness ICER ACER
Total strategies
 Strategy 5 48.183 - 0.003 - - 16,061.091
 Strategy 4 104.076 55.893 0.043 0.04 1397.342 2420.394
 Strategy 7 108.378 60.195 0.137 0.342 176.009 791.084
 Strategy 6 166.415 118.232 2.572 2.568 46.040 64.702
 Strategy 8 255.088 206.905 0.078 0.074 2796.019 3270.367
 Strategy 1 364.571 316.388 1.896 1.893 167.135 192.284
 Strategy 3 561.280 513.097 14.488 14.484 35.425 38.741
 Strategy 2 1475.128 1426.945 93.899 93.895 15.197 15.709
 Strategy 9 3450.017 3401.834 36.020 36.017 94.450 95.780
Acute patient strategies
 Strategy 2 364.571 - 93.899 - - 3.882
 Strategy 1 1475.128 − 1110.557 1.896 -92.002 12.071 778.021
Chronic patient strategies
 Strategy 5 48.18327345 - 0.003 - - 16,061.09115
 Strategy 4 104.0769569 55.89368341 0.043 0.04 1397.342085 2420.394346
 Strategy 7 108.3785836 60.19531012 0.137 0.342 176.0096787 791.0845516
 Strategy 6 166.4153344 118.232061 2.572 2.568 46.04052219 64.70269613
 Strategy 3 561.2803499 513.0970764 14.488 14.484 35.42509503 38.74105121